High-Throughput Screening

In digital biology, High-Throughput Screening (HTS) refers to automated testing method using robotics and ai to rapidly assay thousands to millions of chemical or biological samples. HTS enables rapid identification of active compounds, genes, or targets by testing large chemical libraries against biological assays. AI enhances HTS through hit triaging, activity prediction, and experimental design optimization. Modern ultra-HTS systems screen 100,000+ compounds per day, with AI analyzing complex readouts including imaging, fluorescence, and mass spectrometry data. This term appears frequently in recursion running ai-powered phenotypic hts across millions of compound-gene combinations, making it essential knowledge for industry professionals evaluating AI solutions.

Definition

High-Throughput Screening is defined as: Automated testing method using robotics and AI to rapidly assay thousands to millions of chemical or biological samples. HTS enables rapid identification of active compounds, genes, or targets by testing large chemical libraries against biological assays. AI enhances HTS through hit triaging, activity prediction, and experimental design optimization. Modern ultra-HTS systems screen 100,000+ compounds per day, with AI analyzing complex readouts including imaging, fluorescence, and mass spectrometry data. In practical terms, this means Recursion running AI-powered phenotypic HTS across millions of compound-gene combinations. The acronym High-Throughput Screening stands for HTS. enterprises use high-throughput screening to Novartis using AI-optimized HTS to reduce false positives by 40% in lead discovery. Related terms include: HTS, Automated Screening, Ultra-HTS.

Applications

High-Throughput Screening has widespread applications across digital biology implementations. Pharma companies use high-throughput screening for recursion running ai-powered phenotypic hts across millions of compound-gene combinations. Biotech firms apply this concept to novartis using ai-optimized hts to reduce false positives by 40% in lead discovery. Research institutions leverage high-throughput screening to broad institute deploying automated hts with machine learning hit selection. These practical applications demonstrate why high-throughput screening matters for hts enables rapid identification of active compounds, genes, or targets by testing large chemical libraries against biological assays. ai enhances hts through hit triaging, activity prediction, and experimental design optimization. modern ultra-hts systems screen 100,000+ compounds per day, with ai analyzing complex readouts including imaging, fluorescence, and mass spectrometry data..

Related Concepts

High-Throughput Screening connects to several related digital biology concepts. Key related terms include: AI Drug Discovery, Lab Automation & Robotics, Virtual Screening, Phenotypic Screening. Synonyms: HTS, Automated Screening, Ultra-HTS. Understanding these relationships helps industry professionals navigate the AI landscape and make informed platform decisions. High-Throughput Screening often appears alongside AI Drug Discovery in digital biology discussions.